Interpreting LEAP Study Results: SeaFAC Guidelines for Early Introduction of Peanut in High Risk Infants
Infants at high risk for peanut allergy (persistent, significant eczema affecting more than 75% of skin and/or food allergy to egg) had significant decrease in development of peanut allergy with early (under age 11 months) introduction of peanut into their diet.
Learn how SeaFAC, through ASTHMA, Inc, has been chosen as a study site for a peanut- cutaneous patch study by DBC Technologies called Viaskin.
Help us set up a food allergy oral food challenge clinic which will enable the consortium to participate in future food allergy desensitization research trials. Find out how your dollars can help forward our mission and objectives.